This page shows the result of browsing biomarker from different fieldss.For more information see HELP page.
The total number entries retrieved from this search are 452Biomarker ID | Biomarker | Biomolecule | Subject | Regulation | Biomarker's type | Experiment | Level of significance | Source | PMID |
---|---|---|---|---|---|---|---|---|---|
2393 | Ceruloplasmin | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2394 | CRP | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2395 | Ferritin H | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2396 | AFP | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2397 | Acyl-coenzyme A:cholesterol acyltransferase 1 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2398 | 7-Dehydrocholesterol reductase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2399 | CTP:phosphocholinecytidyl transferase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2400 | Acyl-CoA dehydrogenase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2401 | Fatty acid synthase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2402 | Adenosine deaminase | RNAs | Human | Upregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2403 | CYP450-IIB | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2404 | CYP450-IIC | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2405 | CYP450-IIC17 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2406 | CYP450-IIE1 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2407 | P450 mRNA encoding nifedipine oxidase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2408 | Cholesterol side chain cleavage enzyme P450 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2409 | Lanosterol 14-demethylase cytochrome P450 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2410 | Glutathione S-transferase θ1 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2411 | Glutathione S-transferase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2412 | Glutathione S-transferase M3 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2413 | Glutathione S-transferase θ2 | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2414 | Monoamine oxidase A | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2415 | Chlordecone reductase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2416 | Dihydropteridine reductase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2417 | Zeta-crystallin/quinone reductase | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2418 | Ubiquinol-cytochrome c reductase subunit | RNAs | Human | Downregulated in HCC than non-tumor | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 11752456 |
2419 | IGF2 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2420 | ADAM9 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2421 | STAT3 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2422 | SOCS3 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2423 | cyclin D1 | Protein | Human | Upregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2424 | COL1A1 | Protein | Human | Downregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2425 | SMAD4 | Protein | Human | Downregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2426 | FHIT | Protein | Human | Downregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2427 | SOCS1 | Protein | Human | Downregulated in HCC than normal | Diagnostic | HCC v/s normal | (R2 = 0.85) compared with HCC versus normal liver (R2 = 0.51) | Tissue | 14517841 |
2428 | IGFBP7 | Protein and RNAs | Human | Downregulated in IFN-resistant cells (with fold change 2.963) | Predictive | IGFBP7-positive HCC patients v/s IGFBP7-negative HCC patients | p < 0.05 | Cell line and Tissue | 20407444 |
2429 | reticulon 4 or RTN4 | RNAs | Human | Downregulated in HCC than non-tumor (with fold change of 2.8) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 16463013 |
2430 | RGS-1 | RNAs | Human | Downregulated in HCC than non-tumor (with fold change of 8.5) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 16463013 |
2431 | antiplasmin | RNAs | Human | Downregulated in HCC than non-tumor (with fold change of 3.2) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 16463013 |
2432 | kallikrein B | RNAs | Human | Downregulated in HCC than non-tumor (with fold change of 10.5) | Diagnostic | HCC v/s non-tumor | p < 0.05 | Tissue | 16463013 |
2433 | AURKB | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.36 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2434 | AZI1 | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.46 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2435 | LOC654342 | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.58 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2436 | TPR | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.86 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2437 | CENPI | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.69 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2438 | CBX1 | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.68 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2439 | CCHCR1 | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.57 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2440 | STMN1 | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.52 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2441 | AUP1 | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 1.33 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |
2442 | IQGAP3 | RNAs | Human | Upregulated in highly invasive HCC than less-invasive HCC (with fold change of 2.24 ) | Prognostic | less (L) invasive HCC v/s highly (H) invasive HCC; associated with survival of patients | p < 0.01 | Tissue | 19945130 |